These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6120275)

  • 1. Multicentre study of prevalence of HBV-associated delta infection and liver disease in drug-addicts.
    Raimondo G; Smedile A; Gallo L; Balbo A; Ponzetto A; Rizzetto M
    Lancet; 1982 Jan; 1(8266):249-51. PubMed ID: 6120275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of HBV-associated delta agent: geographical distribution of anti-delta and prevalence in polytransfused HBsAg carriers.
    Rizzetto M; Purcell RH; Gerin JL
    Lancet; 1980 Jun; 1(8180):1215-8. PubMed ID: 6104036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B virus serum markers (HBsAg, antiHBs, antiHBc): prevalence among drug addicts in north-east Italy.
    Floreani A; Chiaramonte M; Zago E; Stivanello A; Trivello R; Renzulli G; Naccarato R
    Boll Ist Sieroter Milan; 1981; 60(6):535-7. PubMed ID: 7344722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B markers in United States drug addicts with special emphasis on the delta hepatitis virus.
    Ponzetto A; Seeff LB; Buskell-Bales Z; Ishak KG; Hoofnagle JH; Zimmerman HJ; Purcell RH; Gerin JL
    Hepatology; 1984; 4(6):1111-5. PubMed ID: 6500507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta agent-a virus in disguise?
    Lancet; 1982 Jan; 1(8266):259-60. PubMed ID: 6120277
    [No Abstract]   [Full Text] [Related]  

  • 6. [Markers of HBV infection in drug addicts].
    Laskus T; Radkowski M; Werezyńska T; Horban A; Lupa E; Cianciara J; Slusarczyk J
    Pol Arch Med Wewn; 1992 Feb; 87(2):104-11. PubMed ID: 1523136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus-associated coinfection and superinfection with delta agent: indistinguishable disease with different outcome.
    Caredda F; Rossi E; d'Arminio Monforte A; Zampini L; Re T; Meroni B; Moroni M
    J Infect Dis; 1985 May; 151(5):925-8. PubMed ID: 3989325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delta agent infection in Melbourne.
    Hoy JF; Hansson BG; Dimitrakakis M; Gust I; Lucas CR
    J Med Virol; 1984; 13(4):339-45. PubMed ID: 6736942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease.
    Novick DM; Farci P; Karayiannis P; Gelb AM; Stenger RJ; Kreek MJ; Thomas HC
    J Med Virol; 1985 Apr; 15(4):351-6. PubMed ID: 3884737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV, HBV, delta-agent and Treponema pallidum infections in two rural African areas.
    de Lalla F; Rizzardini G; Rinaldi E; Santoro D; Zeli PL; Verga G
    Trans R Soc Trop Med Hyg; 1990; 84(1):144-7. PubMed ID: 2189236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta agent infection in acute hepatitis and chronic HBsAg carriers with and without liver disease.
    Craxì A; Raimondo G; Longo G; Giannuoli G; De Pasquale R; Caltagirone M; Patti S; Squadrito G; Pagliaro L
    Gut; 1984 Nov; 25(11):1288-90. PubMed ID: 6500367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of markers of hepatotropic viruses among drug addicts in Warsaw, Poland.
    Laskus T; Radkowski M; Lupa E; Slusarczyk J; Cianciara J; Halama G; Nowicka R
    J Hepatol; 1992 May; 15(1-2):114-7. PubMed ID: 1324268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infections with the hepatitis B virus associated delta agent in an isolated West-African community.
    Goudsmit J; van der Waals F; Ponzetto A; Forzani B; Dobbelaar C
    J Trop Med Hyg; 1984 Dec; 87(6):257-62. PubMed ID: 6534990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-HIV and anti-HBc antibodies and HBsAg in postmortem blood of drug addicts: the picture for 1988.
    Tappero P; Merlino C; Angeretti A; Cavallo R; Vai S; Negro Ponzi A
    Panminerva Med; 1989; 31(3):137-9. PubMed ID: 2601978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers.
    Weller IV; Karayiannis P; Lok AS; Montano L; Bamber M; Thomas HC; Sherlock S
    Gut; 1983 Nov; 24(11):1061-3. PubMed ID: 6629117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to hepatitis delta virus in intravenous drug addicts and male homosexuals in Spain.
    León P; López JA; Contreras G; Echevarría JM
    Eur J Clin Microbiol Infect Dis; 1988 Aug; 7(4):533-5. PubMed ID: 3141166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical aspects of delta infection.
    Moestrup T; Hansson BG; Widell A; Nordenfelt E
    Br Med J (Clin Res Ed); 1983 Jan; 286(6359):87-90. PubMed ID: 6401506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hepatitis B core immunoglobulin M in the serologic evaluation of hepatitis B virus infection and simultaneous infection with type B, delta agent, and non-A, non-B viruses.
    Perrillo RP; Chau KH; Overby LR; Decker RH
    Gastroenterology; 1983 Jul; 85(1):163-7. PubMed ID: 6406288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection with human immunodeficiency virus and hepatitis viruses in Chinese drug addicts.
    Baozhang T; Kaining Z; Jinxing K; Ruchang X; Ming L; Caixia Z; Li T
    Epidemiol Infect; 1997 Dec; 119(3):343-7. PubMed ID: 9440438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Delta hepatitis in Switzerland. Determination of delta antigens and delta antibodies in 397 HBsAg-positive patients (1978-1984)].
    Burkhardt F; Schilt U
    Schweiz Med Wochenschr; 1984 Jul; 114(30):1042-6. PubMed ID: 6474132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.